Pediatric Antidepressant Use After The Black-Box Warning
- 1 May 2009
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 28 (3) , 724-733
- https://doi.org/10.1377/hlthaff.28.3.724
Abstract
In 2004 the Food and Drug Administration (FDA) required a black-box warning on antidepressants that describes a possible suicide risk in children. An analysis of the events, evidence, and FDA actio...Keywords
This publication has 24 references indexed in Scilit:
- National Health Spending In 2007: Slower Drug Spending Contributes To Lowest Rate Of Overall Growth Since 1998Health Affairs, 2009
- Communicating Medical News — Pitfalls of Health Care JournalismNew England Journal of Medicine, 2009
- Frequency of Provider Contact After FDA Advisory on Risk of Pediatric Suicidality With SSRIsAmerican Journal of Psychiatry, 2008
- Effects of Food and Drug Administration Warnings on Antidepressant Use in a National SampleArchives of General Psychiatry, 2008
- Regulatory Errors with Endogenous AgendasAmerican Journal of Political Science, 2007
- A Decade of Direct-to-Consumer Advertising of Prescription DrugsNew England Journal of Medicine, 2007
- Spillover Effects on Treatment of Adult Depression in Primary Care After FDA Advisory on Risk of Pediatric Suicidality With SSRIsAmerican Journal of Psychiatry, 2007
- Peer-Reviewed Publication of Clinical Trials Completed for Pediatric ExclusivityJAMA, 2006
- A matter of perspectiveJournal of General Internal Medicine, 2006
- Effects of the Committee on Safety of Medicines Advice on Antidepressant Prescribing to Children and Adolescents in the UKDrug Safety, 2005